Aptus Capital Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,032
| Closed | -$427K | – | 899 |
|
|
2023
Q2 | $427K | Sell |
2,032
-37,099
| -95% | -$7.8M | 0.01% | 327 |
|
|
2023
Q1 | $7.9M | Buy |
39,131
+38,154
| +3,905% | +$7.7M | 0.21% | 95 |
|
|
2022
Q4 | $213K | Sell |
977
-17,186
| -95% | -$3.74M | 0.01% | 465 |
|
|
2022
Q3 | $3.58M | Sell |
18,163
-7,676
| -30% | -$1.51M | 0.09% | 134 |
|
|
2022
Q2 | $5.53M | Buy |
25,839
+1,323
| +5% | +$283K | 0.14% | 89 |
|
|
2022
Q1 | $6.96M | Buy |
24,516
+6,737
| +38% | +$1.91M | 0.17% | 73 |
|
|
2021
Q4 | $6.7M | Buy |
17,779
+4,312
| +32% | +$1.62M | 0.2% | 61 |
|
|
2021
Q3 | $5.56M | Buy |
+13,467
| New | +$5.56M | 0.14% | 57 |
|